重症监护病房中神经外科急症的严重程度调整资源使用与结局的变异
该研究提取三个国家六所大学医院2015-2017年收治的急诊患者数据,以购买力平价调整后的直接费用为基础,计算标准化资源使用比(SRUR)和标准化院内死亡率比(SMR),分析创伤性脑损伤(TBI)、非创伤性颅内出血(ICH)和蛛网膜下腔出血(SAH)患者中SRUR与SMR的关系及影响因素。结果显示,神经外科急症占全部急诊ICU入院的22%,其直接费用占ICU急诊入院相关直接费用的23.6-26.0%。在非创伤性ICH患者中,较低的成本SRUR与较高的SMR相关;ICU独立组织架构与非创伤性ICH和孤立性/多发伤TBI患者较低的成本SRUR相关,但在非创伤性ICH中与较高的SMR相关。作者强调在资源使用和结局基准比较时进行病例组合调整的重要性。
要点
- 神经外科急症占六所ICU全部急诊入院的22%(6162/28363),其中非创伤性ICH 41%、SAH 23%、多发伤TBI 13%、孤立性TBI 23%。
- 神经外科入院平均费用高于非神经外科入院,占ICU急诊入院相关直接费用的23.6-26.0%。
- 在非创伤性ICH患者中,较低的成本SRUR与较高的SMR相关;其他诊断中未见此关联。
- 较高的医生与床位比与非神经外科入院较低的SMR相关,但在神经外科入院中未见此关联。
- ICU独立组织架构与非创伤性ICH和孤立性/多发伤TBI患者较低的成本SRUR相关,但在非创伤性ICH中与较高的SMR相关。
适用人群与场景
- 2015-2017年在三个国家六所大学医院ICU治疗的急诊患者,包括创伤性脑损伤(TBI)、非创伤性颅内出血(ICH)和蛛网膜下腔出血(SAH)的神经外科急症患者。
研究设计与关键结果
- 研究类型为多中心队列研究,纳入六所大学医院ICU的28363例急诊患者,其中6162例(22%)为神经外科急症入院(非创伤性ICH 41%、SAH 23%、多发伤TBI 13%、孤立性TBI 23%)。
- 神经外科入院平均费用高于非神经外科入院,神经外科入院占ICU急诊入院相关直接费用的23.6-26.0%。
- 较高的医生与床位比与非神经外科入院较低的SMR相关,但在神经外科入院中无此关联。
- 在非创伤性ICH患者中,较低的成本SRUR与较高的SMR相关。
- 在双变量模型中,ICU独立组织架构与非创伤性ICH和孤立性/多发伤TBI患者较低的成本SRUR相关,但在非创伤性ICH中与较高的SMR相关。
- 较高的医生与床位比与SAH患者较高的成本SRUR相关。
- 较大的ICU规模与非创伤性ICH和孤立性TBI患者较高的SMR相关。
- ICU相关因素与非神经外科急诊入院患者的成本SRUR均无关联。
证据类型、等级与局限
- 证据类型:多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在比较资源使用和结局时应进行病例组合调整,因为不同组织和结构因素似乎对神经外科与非神经外科患者的资源使用产生不同影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The correlation between the standardized resource use ratio (SRUR) and standardized hospital mortality ratio (SMR) for neurosurgical emergencies is not known. We studied SRUR and SMR and the factors affecting these in patients with traumatic brain injury (TBI), nontraumatic intracerebral hemorrhage (ICH), and subarachnoid hemorrhage (SAH).
METHODS: We extracted data of patients treated in six university hospitals in three countries (2015-2017). Resource use was measured as SRUR based on purchasing power parity-adjusted direct costs and either intensive care unit (ICU) length of stay (costSRURlength of stay) or daily Therapeutic Intervention Scoring System scores (costSRURTherapeutic Intervention Scoring System). Five a priori defined variables reflecting differences in structure and organization between the ICUs were used as explanatory variables in bivariable models, separately for the included neurosurgical diseases.
RESULTS: Out of 28,363 emergency patients treated in six ICUs, 6,162 patients (22%) were admitted with a neurosurgical emergency (41% nontraumatic ICH, 23% SAH, 13% multitrauma TBI, and 23% isolated TBI). The mean costs for neurosurgical admissions were higher than for nonneurosurgical admissions, and the neurosurgical admissions corresponded to 23.6-26.0% of all direct costs related to ICU emergency admissions. A higher physician-to-bed ratio was associated with lower SMRs in the nonneurosurgical admissions but not in the neurosurgical admissions. In patients with nontraumatic ICH, lower costSRURs were associated with higher SMRs. In the bivariable models, independent organization of an ICU was associated with lower costSRURs in patients with nontraumatic ICH and isolated/multitrauma TBI but with higher SMRs in patients with nontraumatic ICH. A higher physician-to-bed ratio was associated with higher costSRURs for patients with SAH. Larger units had higher SMRs for patients with nontraumatic ICH and isolated TBI. None of the ICU-related factors were associated with costSRURs in nonneurosurgical emergency admissions.
CONCLUSIONS: Neurosurgical emergencies constitute a major proportion of all emergency ICU admissions. A lower SRUR was associated with higher SMR in patients with nontraumatic ICH but not for the other diagnoses. Different organizational and structural factors seemed to affect resource use for the neurosurgical patients compared with nonneurosurgical patients. This emphasizes the importance of case-mix adjustment when benchmarking resource use and outcomes.
参考来源
- Raj R, Moser A, Starkopf J, et al. Variation in Severity-Adjusted Resource use and Outcome for Neurosurgical Emergencies in the Intensive Care Unit. Neurocrit Care. 2023. PMID: 37100975. doi:10.1007/s12028-023-01723-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。